Sage Therapeutics - The FDA has granted Fast Track Designation to SAGE-718.katrina4384Feb 26, 20220 min readUpdated: Mar 31, 2022
Community Update: Novartis development of Votoplam in HD: INVEST-HD Phase 3 trial information now available
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease
Comments